900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Down's syndrome NOS	Complete trisomy 21 syndrome
Down's syndrome NOS	Complete trisomy 21 syndrome
Doxazosin mesylate 8mg tablet	Doxazosin (as doxazosin mesilate) 8 mg oral tablet
Doxepin hydrochloride 10mg/mL oral solution	Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug)
Doxepin metabolite	Product containing doxepin (medicinal product)
Doxorubicin hydrochloride 10mg injection solution vial	Doxorubicin hydrochloride 10 mg powder for solution for injection vial
Doxorubicin hydrochloride 20mg injection solution vial	Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug)
Doxorubicin liposomal 20mg/10ml injection	Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug)
Doxycycline 100mg dispersible tablet	Doxycycline 100 mg orodispersible tablet
Doxycycline 40mg m/r capsule	Product containing precisely doxycycline 40 milligram/1 each prolonged-release oral capsule (clinical drug)
Doxycycline 75mg orally disintegrating tablet	Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet
Doxycycline calcium 50mg/5mL syrup	Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug)
Doxycycline hyclate 10% subgingival delivery system	Product containing only doxycycline in oromucosal dose form (medicinal product form)
Doxycycline hyclate 200mg injection (pdr for recon)	Product containing only doxycycline in parenteral dose form (medicinal product form)
Doxycycline hyclate 200mg powder for injection solution vial	Product containing only doxycycline in parenteral dose form (medicinal product form)
Doxycycline monohydrate 25mg/5mL suspension	Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension
Drain insertion - action	Insertion - action (qualifier value)
Drainage bleb, functional	Functional filtering bleb (finding)
Drainage of boil of skin NEC	Drainage of boil of skin
Drainage of cyst NEC	Drainage procedure
Drainage of cyst of pancreas into jejunum NEC	Pancreaticocystojejunostomy
Drainage of female perineal abscess	Drainage of perineal abscess (procedure)
Drainage of male periurethral abscess	Drainage of periurethral abscess (procedure)
Drainage of organ NOC	Drainage procedure
Drainage of organ NOC NOS	Drainage procedure
Drechslera longirostrata	Exserohilum longirostratum
Dressing - action	Application - action
Dried factor IX fraction heated 600iu powder and solvent for injection solution vial	Product containing only coagulation factor IX in parenteral dose form (medicinal product form)
Dried factor IX fraction heated 600iu powder for conventional release solution for injection solution vial	Product containing only coagulation factor IX in parenteral dose form (medicinal product form)
Drilling of organ NOC	Drilling
Drimaren brilliant yellow	Textile colours and finishes patch test substance
Drop attacks in middle-aged woman	Drop attack
Drostanolone propionate allergy	Allergy to drostanolone (finding)
Drotrecogin alfa (activated) 5mg powder for infusion solution vial	Drotrecogin alfa 5 mg powder for solution for injection vial
Drotrecogin alfa 20mg powder for infusion solution vial	Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Drug	Pharmaceutical / biologic product (product)
Drug aerosol, 0,01%	Drug aerosol
Drug aerosol, 0,04%	Drug aerosol
Drug aerosol, 0,5%	Drug aerosol
Drug cream, 0,01%	Cream
Drug cream, 0,02%	Cream
Drug cream, 0,025%	Cream
Drug cream, 0,05%	Cream
Drug cream, 0,1%	Cream
Drug cream, 0,25%	Cream
Drug cream, 0,5%	Cream
Drug cream, 1%	Cream
Drug cream, 2,5%	Cream
Drug dependence	Substance dependence (disorder)
Drug dependence - unspecified whether during pregnancy or the puerperium	Substance dependence during pregnancy, childbirth and/or puerperium (disorder)
Drug dependence NOS	Substance dependence (disorder)
Drug dependence NOS	Substance dependence (disorder)
Drug dependence during childbirth, puerperium (& pregnancy)	Substance dependence during pregnancy, childbirth and/or puerperium (disorder)
Drug dependence during pregnancy, childbirth and the puerperium	Substance dependence during pregnancy, childbirth and/or puerperium (disorder)
Drug dependence during pregnancy, childbirth or the puerperium NOS	Substance dependence during pregnancy, childbirth and/or puerperium (disorder)
Drug dependence in childbirth	Substance dependence in childbirth
Drug dependence in mother complicating pregnancy, childbirth AND/OR puerperium	Substance dependence in mother complicating pregnancy, childbirth and/or puerperium (disorder)
Drug dependence in remission	Substance dependence in remission
Drug dependence, continuous	Substance dependence, continuous
Drug dependence, episodic	Substance dependence, episodic (disorder)
Drug for supraventricular arrhythmia	Antiarrhythmic agent (substance)
Drug for ventricular arrhythmia	Antiarrhythmic agent (substance)
Drug gel, 0,05%	Gel
Drug gel, 0,1%	Gel
Drug gel, 0,25%	Gel
Drug groups and agents primarily acting on skin adverse reaction	Adverse reaction to drug
Drug groups primarily affecting autonomic nervous system adverse reaction	Adverse reaction to drug
Drug groups primarily affecting cardiovascular system adverse reaction	Adverse reaction to drug
Drug groups primarily affecting central nervous system adverse reaction	Adverse reaction to drug
Drug groups primarily affecting gastrointestinal system adverse reaction	Adverse reaction to drug
Drug groups primarily affecting musculoskeletal system adverse reaction	Adverse reaction to drug
Drug groups primarily affecting respiratory system adverse reaction	Adverse reaction to drug
Drug groups primarily affecting the autonomic nervous system	Product containing autonomic agent (product)
Drug hypersensitivity	Propensity to adverse reactions to drug
Drug hypersensitivity (& [NOS])	Propensity to adverse reactions to drug
Drug hypersensitivity NOS	Propensity to adverse reactions to drug
Drug induced rash (& ingestion dermatitis)	Dermatitis caused by substance taken via oral route (disorder)
Drug level in urine specimen above therapeutic range	Urine substance level above reference range (finding)
Drug ointment, 0,025%	Ointment
Drug ointment, 0,05%	Ointment
Drug ointment, 0,1%	Ointment
Drug ointment, 0,2%	Ointment
Drug ointment, 0,25%	Ointment
Drug ointment, 1%	Ointment
Drug ointment, 2,5%	Ointment
Drug reaction - CNS drug	Adverse reaction to drug
Drug reaction - CNS drug	Adverse reaction to drug
Drug reaction - CNS drug NOS	Adverse reaction to drug
Drug reaction - CNS drug NOS	Adverse reaction to drug
Drug reaction to analgesic NOS	Analgesic adverse reaction
Drug reaction to analgesic NOS	Analgesic adverse reaction
Drug specific allergen extract	Pharmaceutical / biologic product (product)
Drug therapy status	Drug therapy with explicit context
Drug withdrawal	Substance withdrawal
Drug withdrawal seizure	Seizure co-occurrent and due to substance withdrawal
Drug withdrawal syndrome	Substance withdrawal
Drug withdrawal syndrome	Substance withdrawal
Drug, medicament or biological substance	Drug or medicament (substance)
Drug, medicament, or biological substance in urine above reference range	Urine substance level above reference range (finding)
Drug-induced impotence	Erectile dysfunction caused by drug
Drug-induced nephrogenic diabetes insipidus	Acquired vasopressin resistance

Start Previous Page 50 of 195 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)